LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Michael Tomsicek, Cubist’s SVP & Chief Financial Officer, will present at the Jefferies 2014 Healthcare Conference on Wednesday, November 19, to discuss the company’s business activities, financial outlook, and current news.
The presentation will be held at the Waldorf Hilton hotel in London on Wednesday, November 19, 2014 at 1:00 p.m. (GMT).
This presentation will be accessible live through Cubist’s website at www.cubist.com in the Investor Relations Conference Calendar section and will remain available there for a period of 90 days after the presentations.
Cubist Pharmaceuticals, Inc. is a global biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist’s corporate headquarters is located in Lexington, Massachusetts, United States with its international headquarters located in Zurich, Switzerland. Additional information can be found on the Company’s web sites: www.cubist.com and www.cubist.ch/. Also, connect with Cubist on Twitter @cubistbiopharma and @cubistcareers, LinkedIn, or YouTube.